As of 2025-11-01, the Relative Valuation of Gemina Laboratories Ltd (GLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.40 CAD, the upside of Gemina Laboratories Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-10-29 | -8.74 |
| 2025-10-22 | -10.40 |
| 2025-10-10 | -9.96 |
| 2025-10-06 | -10.62 |
| 2025-10-01 | -11.07 |
| 2025-09-25 | -11.07 |
| 2025-09-19 | -11.07 |
| 2025-09-17 | -11.73 |
| 2025-09-12 | -12.17 |
| 2025-09-11 | -12.17 |
| 2025-09-09 | -7.08 |
| 2025-09-05 | -9.52 |
| 2025-09-03 | -9.96 |
| 2025-09-02 | -8.85 |
| 2025-08-27 | -10.84 |
| 2025-08-26 | -11.07 |
| 2025-08-25 | -11.07 |
| 2025-08-21 | -13.28 |
| 2025-08-15 | -11.07 |
| 2025-08-14 | -11.07 |
| 2025-08-13 | -11.07 |
| 2025-08-12 | -12.84 |
| 2025-08-07 | -13.28 |
| 2025-08-06 | -14.83 |
| 2025-08-05 | -16.38 |